20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6288 | Mozavaptan | OPC31260l,OPC-31260 | Vasopressin Receptor |
Mozavaptan (OPC-31260) is a competitive vasopressin receptor antagonist for both V1 and V2 receptors with IC50 of 1.2 μM and 14 nM, respectively. | |||
T64174 | Vasopressin V2 receptor antagonist 1 | ||
Vasopressin V2 receptor antagonist 1 (Compound 4g) is a vasopressin V2receptor (V2R) antagonist (Ki: 3.8 nM). dominant polycystic kidney disease (ADPKD). | |||
T7303 | LIXIVAPTAN | VPA-985,WAY-VPA 985 | Vasopressin Receptor |
Lixivaptan (VPA-985) is an orally active and selective vasopressin receptor V2 antagonist(Ki = 2.3 nM) | |||
T6453 | Conivaptan hydrochloride | Vaprisol,Conivaptan HCl,YM 087 | Vasopressin Receptor |
Conivaptan hydrochloride (Vaprisol) is an orally active vasopressin V2 and V1A receptor antagonist, used in the therapy of hypervolemic hyponatremia and euvolemic. | |||
T15273 | Fedovapagon | VA483,A106483 | Vasopressin Receptor |
Fedovapagon (VA106483) is a selective and potent agonist of the vasopressin V2 receptor (V2R) that inhibits the growth of intersegmental vessels in zebrafish. Fedovapagon can be used to study overactive bladder, nocturia... | |||
T5144 | Desmopressin acetate (16679-58-6 free base) | Desmopressin acetate,DDAVP | Vasopressin Receptor |
Desmopressin acetate (16679-58-6 free base) (DDAVP) is the synthetic analog of the antidiuretic hormone arginine vasopressin. Vasopressin Receptor The antidiuretic properties of desmopressin have led to its use in polyur... | |||
T2326 | Tolvaptan | OPC-41061 | Vasopressin Receptor , Autophagy |
Tolvaptan (OPC-41061) is an orally bioavailable, selective, arginine vasopressin receptor 2 (V2, AVPR2) antagonist that can be used to treat hyponatremia. | |||
TP2082L | D[Cha4]-AVP acetate(500170-27-4 free base) | Vasopressin Receptor | |
d[Cha4]-AVP acetate is a potent and selective human vasopressin V1B receptor agonist (Ki values are 1.2, 151, 240 and 750 nM for V1B, V1A, Oxytocin and V2 receptors respectively). Stimulates ACTH and corticosterone secre... | |||
T28629 | RWJ 676070 | RWJ676070,RWJ-676070 | |
RWJ 676070 is an antagonist of vasopressin V1A/V2 receptor. | |||
T29178 | YM 471 | YM-471,YM471 | |
YM 471 is a non-peptide arginine vasopressin (AVP) V1A and V2 receptor antagonist with oral activity. | |||
T24759 | Satavaptan fumarate | SR-121463A,SR 121463 A,SR-121463 A,SR121463A | |
Satavaptan fumarate is a selective antagonist of the non-peptide vasopressin V2 receptor. | |||
T24370 | L-368899 free base | L 368899,L 368,899,L368,899,L-368899,L368899,L-368,899 | |
L-368899 is a non-peptide and orally active antagonist of oxytocin receptor (IC50: 8.9 nM). It displays 40-fold selectivity over vasopressin V1a and V2 receptors (IC50: 370 and 570 nM respectively). | |||
T27965 | M-0002 | RWJ-351647,SPD556,SPD-556,M0002,RWJ351647 | |
M-0002, a vasopressin V2 receptor antagonist, is used potentially for the treatment of ascites. | |||
T28664 | Satavaptan | SR121463,SR 121463,SR-121463 | |
Satavaptan is a vasopressin V2 receptor antagonist. Satavaptan improves the control of ascites in cirrhosis. | |||
T17251 | VNA-932 | WAY-VNA 932 | Others |
VNA-932 is an agonist of the vasopressin V2-receptor (IC50: 80.3 nM and 778 nM in human-V2 binding and V1a binding assay). | |||
T62906 | Lazuvapagon | ||
Lazuvapagon is a vasopressin V2 receptor agonist that can be used to study enuresis. | |||
TP2082 | D[Cha4]-AVP | ||
Potent and selective human vasopressin V1B receptor agonist (Ki values are 1.2, 151, 240 and 750 nM for V1B, V1A, Oxytocin and V2 receptors respectively). Stimulates ACTH and corticosterone secretion and exhibits negligi... | |||
T16934 | SRX246 | Others | |
SRX246 has no interaction at V1b and V2 receptors. SRX246 shows negligible binding at 64 other receptors classes, including 35 G-proteincoupled receptors. SRX246 is a potent and CNS-penetrant vasopressin 1a (V1a) recepto... | |||
TP1927 | D[Leu4,Lys8]-VP | ||
Selective vasopressin V1B receptor agonist (Ki values are 0.16, 64, 100 and 3800 nM for V1B, oxytocin, V2 and V1A receptors respectively). Displays weak antidiuretic, vasopressor and in vitro oxytocic activities. | |||
T75933 | D[Cha4]-AVP TFA | ||
d[Cha4]-AVP TFA is a potent and selective agonist for the vasopressin (AVP) V1b receptor, displaying a high affinity with a K i of 1.2 nM. It exhibits greater selectivity for the V1b receptor over the V1a receptor, V2 re... |